Kyverna Therapeutics, Inc. (KYTX)
7.66
-0.19
(-2.42%)
USD |
NASDAQ |
Jun 10, 16:00
7.645
-0.02
(-0.20%)
After-Hours: 20:00
Kyverna Therapeutics EPS Diluted (Quarterly) : -0.6574 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.6574 |
| December 31, 2025 | -0.8017 |
| September 30, 2025 | -0.8473 |
| June 30, 2025 | -0.9735 |
| March 31, 2025 | -1.033 |
| December 31, 2024 | -0.8675 |
| September 30, 2024 | -0.799 |
| Date | Value |
|---|---|
| June 30, 2024 | -0.6676 |
| March 31, 2024 | -1.124 |
| December 31, 2023 | -0.4793 |
| September 30, 2023 | -0.3587 |
| June 30, 2023 | -0.3036 |
| March 31, 2023 | -0.2584 |
| December 31, 2022 | -0.197 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| X4 Pharmaceuticals, Inc. | -0.1603 |
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| Oncolytics Biotech, Inc. | -0.0823 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | 2.878 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -39.73M |
| Total Expenses (Quarterly) | 39.73M |
| Enterprise Value | 260.99M |
| Earnings Yield | -42.82% |
| Normalized Earnings Yield | -42.82 |